Navigation Links
Cyphort Announces $15.5 Million Series B Funding Led by Trinity Ventures

San Francisco, CA (PRWEB) October 28, 2013

Cyphort, Inc. (, an advanced threat monitoring and mitigation platform, today announced that it closed in $15.5 million Series B funding. The oversubscribed round was led by Trinity Ventures with participation from existing investors; Foundation Capital and Matrix Capital. Fred Wang, General Partner of Trinity Ventures, will join Cyphort's Board of Directors. The latest round of funds will be used to accelerate delivery. Additionally, the company announced the hire of Shishir Singh, former VP of Network Security Engineering from McAfee as Cyphort’s VP of engineering. The appointment is part of Cyphort’s strategy to aggressively expand sales, marketing and engineering to meet increasing demand from enterprise customers for advanced persistent threats (APTs) protection.

“Trinity Ventures is the ideal partner to join our current investors, and Fred’s knowledge of the enterprise space and strategic guidance will help us scale all facets of our business to transform the way enterprises protect their systems,” said Cyphort CEO, Manoj Leelanivas. "Enterprises are under constant attack from malicious software, compromising the security of sensitive information and exposing the company, its employees, and its customers to unprecedented levels of fraudulent losses. Signature and heuristic-based detection have proven unsuccessful in keeping pace with the complexity of advanced modern attacks. Cyphort’s approach is much more comprehensive and accurate in defending against these attacks."

As the industry’s first and only advanced threat solution to combine best-in-class multi-OS threat detection, actionable threat intelligence, and distributed multi-application architecture, Cyphort delivers an unprecedented level of security to the enterprise. Cyphort’s platform leverages a unique blend of multi-phase behavioral analysis, machine learning, and correlation to provide businesses with real-time detection, context and mitigation for advanced malware attacks that bypass traditional security and first generation APT solutions.

"New and increasingly sophisticated cyber-attacks continue to evolve, leaving companies inadequately protected by their current anti-virus, intrusion protection, and first generation behavior-based solutions," said Fred Wang of Trinity Ventures. “Cyphort is bridging a critical, emerging security gap with its new threat monitoring, detection and protection platform and we are excited to be a part of this opportunity.”

Within the past 12 months, the cost of Cybercrime in the US has risen by approximately 30%. Concurrently, Cyphort has experienced tremendous growth in customer interest and traction. To keep pace with market demand for its solutions in the face of such a dramatic increase in threats, Cyphort plans to hire in critical departments including Sales, Marketing and Engineering. The appointment of industry veteran Shishir Singh as Vice President of Engineering, who previously led engineering teams for well known security companies such as McAfee, IronPort, Cisco and Blue Coat, highlights Cyphort’s dedication in attracting and retaining top talent from the security industry.

For more information on all open positions, please visit:

About Trinity Ventures

Trinity Ventures is a leading venture capital firm with nearly 30 years of experience investing in early-stage technology companies. Through 11 successful funds, the firm has maintained the industry’s lowest general partner-to-fund ratio, underscoring its commitment to entrepreneurs and founders. Trinity’s collaborative approach, based on personal engagement, mutual respect, and goal alignment, consistently delivers out-sized returns to entrepreneurs and investors. Trinity has worked with more than 250 companies, helping to transform revolutionary ideas into market-leading businesses. With more than $1.25 billion under management, the firm’s expertise focuses primarily on B2C, eCommerce, mobile, cloud and SaaS. Some of Trinity’s game-changing investments include: Act-On Software. Aruba Networks (ARUN), Blue Nile (NILE),, Extreme Networks (EXTR), Infoblox (BLOX). KIXEYE, MaxPoint, New Relic, Starbucks (SBUX), TubeMogul and zulily, For more information, please visit

About Cyphort, Inc.

Cyphort is transforming security with an advanced threat protection platform that provides complete defense against current and emerging advanced persistent threats, targeted attacks and zero day vulnerabilities. Cyphort’s solution accurately detects next generation malware, delivers actionable intelligence with the ability to verify, mitigate and prevent future attacks. Industry experts with backgrounds in advanced threat research from government intelligence agencies and premier network security companies have come together to build Cyphort’s security solution, designed to meet the yet unmet needs of protecting enterprises from today’s modern malware attacks.

Cyphort is a privately-held company headquartered in San Jose, California, USA. For more information, please visit:

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. AFAR announces the 2012 Hartford Centers of Excellence in Geriatric Medicine awards
2. Bascom Palmer Eye Institute announces breakthrough for degenerative vision disorder
3. University of Houston Graduate College of Social Work announces partnership with MD Anderson
4. The Ludwig Institute for Cancer Research announces launch of iTeos Therapeutics SA
5. AGA announces prestigious awards recognition recipients
6. Announces The Top 3 Heart Rate Monitors
7. Article Marketing Company Content Writing King Announces Training Of New Graphic Design Artist
8. Zane Benefits Announces Wellness HRAs: A New Way to Reward Healthy Employees
9. San Francisco’s Advanced Male Medical Center Announces Discount, Discusses Erectile Dysfunction
10. Insulite Labs announces the launch of the PCOS Inspiration Hour, a one hour virtual gathering place for women with PCOS and other women’s health issues to come together.
11. NYC Doc Announces 3 Surprising Ways to Beat Seasonal Allergies
Post Your Comments:
(Date:12/1/2015)... NY (PRWEB) , ... December 01, 2015 , ... ... in the 1980s we have seen vast improvements in scientific research and discoveries, ... significant strides, providing increased hope and relief to those affected by HIV/AIDS. Mediaplanet’s ...
(Date:12/1/2015)... New York, NY (PRWEB) , ... December 01, ... ... cause of non-traumatic limb amputations in the United States. Podiatrists are well aware ... (failure to adopt therapeutic behaviors) are often catastrophic contributors to diseases of the ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Imaging Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), ... at the Radiological Society of North America (RSNA) 2015 annual meeting through December ...
(Date:12/1/2015)... ... December 01, 2015 , ... Lutronic, a leading innovator of aesthetic and ... to the devices for sale in the United States. Clarity is a Superior ... nm Nd:YAG lasers, into a single platform that is easy to own and operate. ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... and SACC-USA through membership and leadership since 2008. Gary Bruce, President of PartnerTech ... . Gary has spent a significant amount of time in Sweden since joining ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , December 1, 2015 ... new market research report "Nucleic Acid Labeling Market by ... Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription, ... published by MarketsandMarkets, The global market is expected to ... Million in 2015, growing at a CAGR of 8.65%. ...
(Date:12/1/2015)... , December 1, 2015 Russia ... clinical trials. 70% of new drugs registered in Europe ... Russia . --> Russia has always been ... of new drugs registered in Europe in 2015 ... --> Russia has always been a country ...
(Date:12/1/2015)... 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage ... announced today that the company will present at the LD ... at the Luxe Sunset Boulevard Hotel in Los ... Relmada Therapeutics, will present on Thursday, December 3, at 9:00 ... . Please register at least 10 minutes prior to the ...
Breaking Medicine Technology: